Salivary metabolite signatures of oral cancer and leukoplakia

Jie Wei, Guoxiang Xie, Zengtong Zhou, Peng Shi, Yunping Qiu, Xiaojiao Zheng, Tianlu Chen, Mingming Su, Aihua Zhao, Wei Jia

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Oral cancer, one of the six most common human cancers with an overall 5-year survival rate of <50%, is often not diagnosed until it has reached an advanced stage. The aim of the current study is to explore salivary metabolomics as a disease diagnostic and stratification tool for oral cancer and leukoplakia and evaluate the potential of salivary metabolome for detection of oral squamous cell carcinoma (OSCC). Saliva metabolite profiling for a group of 37 OSCC patients, 32 oral leukoplakia (OLK) patients and 34 healthy subjects was performed using ultraperformance liquid chromatography coupled with quadrupole/time-of-flight mass spectrometry in conjunction with multivariate statistical analysis. The OSCC, OLK and healthy control groups demonstrate characteristic salivary metabolic signatures. A panel of five salivary metabolites including γ-aminobutyric acid, phenylalanine, valine, n-eicosanoic acid and lactic acid were selected using OPLS-DA model with S-plot. The predictive power of each of the five salivary metabolites was evaluated by receiver operating characteristic curves for OSCC. Valine, lactic acid and phenylalanine in combination yielded satisfactory accuracy (0.89, 0.97), sensitivity (86.5% and 94.6%), specificity (82.4% and 84.4%) and positive predictive value (81.6% and 87.5%) in distinguishing OSCC from the controls or OLK, respectively. The utility of salivary metabolome diagnostics for oral cancer is successfully demonstrated in this study and these results suggest that metabolomics approach complements the clinical detection of OSCC and stratifies the two types of lesions, leading to an improved disease diagnosis and prognosis.

Original languageEnglish (US)
Pages (from-to)2207-2217
Number of pages11
JournalInternational Journal of Cancer
Volume129
Issue number9
DOIs
StatePublished - Nov 1 2011
Externally publishedYes

Fingerprint

Oral Leukoplakia
Mouth Neoplasms
Squamous Cell Carcinoma
Metabolomics
Metabolome
Valine
Phenylalanine
Eicosanoic Acids
Lactic Acid
Aminobutyrates
Saliva
ROC Curve
Liquid Chromatography
Mass Spectrometry
Healthy Volunteers
Multivariate Analysis
Survival Rate
Control Groups

Keywords

  • metabolomics
  • multivariate statistical analysis
  • oral squamous cell carcinoma
  • receiver operating characteristics
  • saliva
  • ultraperformance liquid chromatography quadrupole-time of flight mass spectrometry

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Wei, J., Xie, G., Zhou, Z., Shi, P., Qiu, Y., Zheng, X., ... Jia, W. (2011). Salivary metabolite signatures of oral cancer and leukoplakia. International Journal of Cancer, 129(9), 2207-2217. https://doi.org/10.1002/ijc.25881

Salivary metabolite signatures of oral cancer and leukoplakia. / Wei, Jie; Xie, Guoxiang; Zhou, Zengtong; Shi, Peng; Qiu, Yunping; Zheng, Xiaojiao; Chen, Tianlu; Su, Mingming; Zhao, Aihua; Jia, Wei.

In: International Journal of Cancer, Vol. 129, No. 9, 01.11.2011, p. 2207-2217.

Research output: Contribution to journalArticle

Wei, J, Xie, G, Zhou, Z, Shi, P, Qiu, Y, Zheng, X, Chen, T, Su, M, Zhao, A & Jia, W 2011, 'Salivary metabolite signatures of oral cancer and leukoplakia', International Journal of Cancer, vol. 129, no. 9, pp. 2207-2217. https://doi.org/10.1002/ijc.25881
Wei, Jie ; Xie, Guoxiang ; Zhou, Zengtong ; Shi, Peng ; Qiu, Yunping ; Zheng, Xiaojiao ; Chen, Tianlu ; Su, Mingming ; Zhao, Aihua ; Jia, Wei. / Salivary metabolite signatures of oral cancer and leukoplakia. In: International Journal of Cancer. 2011 ; Vol. 129, No. 9. pp. 2207-2217.
@article{fc85d164dc1c456cbb1e4fee3fe5b972,
title = "Salivary metabolite signatures of oral cancer and leukoplakia",
abstract = "Oral cancer, one of the six most common human cancers with an overall 5-year survival rate of <50{\%}, is often not diagnosed until it has reached an advanced stage. The aim of the current study is to explore salivary metabolomics as a disease diagnostic and stratification tool for oral cancer and leukoplakia and evaluate the potential of salivary metabolome for detection of oral squamous cell carcinoma (OSCC). Saliva metabolite profiling for a group of 37 OSCC patients, 32 oral leukoplakia (OLK) patients and 34 healthy subjects was performed using ultraperformance liquid chromatography coupled with quadrupole/time-of-flight mass spectrometry in conjunction with multivariate statistical analysis. The OSCC, OLK and healthy control groups demonstrate characteristic salivary metabolic signatures. A panel of five salivary metabolites including γ-aminobutyric acid, phenylalanine, valine, n-eicosanoic acid and lactic acid were selected using OPLS-DA model with S-plot. The predictive power of each of the five salivary metabolites was evaluated by receiver operating characteristic curves for OSCC. Valine, lactic acid and phenylalanine in combination yielded satisfactory accuracy (0.89, 0.97), sensitivity (86.5{\%} and 94.6{\%}), specificity (82.4{\%} and 84.4{\%}) and positive predictive value (81.6{\%} and 87.5{\%}) in distinguishing OSCC from the controls or OLK, respectively. The utility of salivary metabolome diagnostics for oral cancer is successfully demonstrated in this study and these results suggest that metabolomics approach complements the clinical detection of OSCC and stratifies the two types of lesions, leading to an improved disease diagnosis and prognosis.",
keywords = "metabolomics, multivariate statistical analysis, oral squamous cell carcinoma, receiver operating characteristics, saliva, ultraperformance liquid chromatography quadrupole-time of flight mass spectrometry",
author = "Jie Wei and Guoxiang Xie and Zengtong Zhou and Peng Shi and Yunping Qiu and Xiaojiao Zheng and Tianlu Chen and Mingming Su and Aihua Zhao and Wei Jia",
year = "2011",
month = "11",
day = "1",
doi = "10.1002/ijc.25881",
language = "English (US)",
volume = "129",
pages = "2207--2217",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Salivary metabolite signatures of oral cancer and leukoplakia

AU - Wei, Jie

AU - Xie, Guoxiang

AU - Zhou, Zengtong

AU - Shi, Peng

AU - Qiu, Yunping

AU - Zheng, Xiaojiao

AU - Chen, Tianlu

AU - Su, Mingming

AU - Zhao, Aihua

AU - Jia, Wei

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Oral cancer, one of the six most common human cancers with an overall 5-year survival rate of <50%, is often not diagnosed until it has reached an advanced stage. The aim of the current study is to explore salivary metabolomics as a disease diagnostic and stratification tool for oral cancer and leukoplakia and evaluate the potential of salivary metabolome for detection of oral squamous cell carcinoma (OSCC). Saliva metabolite profiling for a group of 37 OSCC patients, 32 oral leukoplakia (OLK) patients and 34 healthy subjects was performed using ultraperformance liquid chromatography coupled with quadrupole/time-of-flight mass spectrometry in conjunction with multivariate statistical analysis. The OSCC, OLK and healthy control groups demonstrate characteristic salivary metabolic signatures. A panel of five salivary metabolites including γ-aminobutyric acid, phenylalanine, valine, n-eicosanoic acid and lactic acid were selected using OPLS-DA model with S-plot. The predictive power of each of the five salivary metabolites was evaluated by receiver operating characteristic curves for OSCC. Valine, lactic acid and phenylalanine in combination yielded satisfactory accuracy (0.89, 0.97), sensitivity (86.5% and 94.6%), specificity (82.4% and 84.4%) and positive predictive value (81.6% and 87.5%) in distinguishing OSCC from the controls or OLK, respectively. The utility of salivary metabolome diagnostics for oral cancer is successfully demonstrated in this study and these results suggest that metabolomics approach complements the clinical detection of OSCC and stratifies the two types of lesions, leading to an improved disease diagnosis and prognosis.

AB - Oral cancer, one of the six most common human cancers with an overall 5-year survival rate of <50%, is often not diagnosed until it has reached an advanced stage. The aim of the current study is to explore salivary metabolomics as a disease diagnostic and stratification tool for oral cancer and leukoplakia and evaluate the potential of salivary metabolome for detection of oral squamous cell carcinoma (OSCC). Saliva metabolite profiling for a group of 37 OSCC patients, 32 oral leukoplakia (OLK) patients and 34 healthy subjects was performed using ultraperformance liquid chromatography coupled with quadrupole/time-of-flight mass spectrometry in conjunction with multivariate statistical analysis. The OSCC, OLK and healthy control groups demonstrate characteristic salivary metabolic signatures. A panel of five salivary metabolites including γ-aminobutyric acid, phenylalanine, valine, n-eicosanoic acid and lactic acid were selected using OPLS-DA model with S-plot. The predictive power of each of the five salivary metabolites was evaluated by receiver operating characteristic curves for OSCC. Valine, lactic acid and phenylalanine in combination yielded satisfactory accuracy (0.89, 0.97), sensitivity (86.5% and 94.6%), specificity (82.4% and 84.4%) and positive predictive value (81.6% and 87.5%) in distinguishing OSCC from the controls or OLK, respectively. The utility of salivary metabolome diagnostics for oral cancer is successfully demonstrated in this study and these results suggest that metabolomics approach complements the clinical detection of OSCC and stratifies the two types of lesions, leading to an improved disease diagnosis and prognosis.

KW - metabolomics

KW - multivariate statistical analysis

KW - oral squamous cell carcinoma

KW - receiver operating characteristics

KW - saliva

KW - ultraperformance liquid chromatography quadrupole-time of flight mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=80052272696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052272696&partnerID=8YFLogxK

U2 - 10.1002/ijc.25881

DO - 10.1002/ijc.25881

M3 - Article

VL - 129

SP - 2207

EP - 2217

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 9

ER -